Clearstead Advisors, LLC Gossamer Bio, Inc. Transaction History
Clearstead Advisors, LLC
- $6.94 Billion
- Q2 2025
A detailed history of Clearstead Advisors, LLC transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Clearstead Advisors, LLC holds 23,550 shares of GOSS stock, worth $60,523. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,550
Previous 22,000
7.05%
Holding current value
$60,523
Previous $24,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding GOSS
# of Institutions
136Shares Held
159MCall Options Held
2.89MPut Options Held
130K-
Octagon Capital Advisors LP New York, NY18.4MShares$47.2 Million8.57% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$46.5 Million1.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$29.3 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$20.7 Million5.25% of portfolio
-
Acadian Asset Management LLC Boston, MA7.15MShares$18.4 Million0.02% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $241M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...